Targeting Aging to Improve Healthspan
Author Information
Author(s): Espinoza Sara, Gonzales Mitzi, Musi Nicolas
Primary Institution: Cedars-Sinai Medical Center
Hypothesis
By targeting aging, we may prevent or delay several age-related diseases and increase healthspan.
Conclusion
Clinical trials are needed to determine the efficacy of pharmacological interventions aimed at improving healthspan.
Supporting Evidence
- The geroscience hypothesis suggests that targeting aging can prevent age-related diseases.
- Clinical trials are necessary to assess the safety and efficacy of new therapies.
- A patient-centered approach is essential for tailoring interventions.
Takeaway
Scientists think that if we can slow down aging, we can help people live healthier for longer. They are testing different medicines to see if they work.
Methodology
Clinical trials of candidate agents are underway to examine pharmacological interventions.
Potential Biases
The majority of physicians providing care to older adults may not be geriatricians, which could lead to a lack of knowledge in geroscience.
Limitations
Interventions must not worsen existing medical conditions or lead to negative side effects.
Participant Demographics
Older adults, though specific demographics are not provided.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website